Daxor Corporation (now NASDAQ:DXR) is a medical instrumentation firm in the biotechnology arena focused on blood volume measurement. The firm develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. As the pioneer in blood volume analysis, Daxor management provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from a User's BVA system throughout their facility. With a long-standing commitment to improving care and numerous studies validating thefirm's technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis wit the firm's vision being optimal blood volume for all.
